|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 16176456.8 (espacenet) (Federated) (European Patent Register), 20090107 | | Patent/reg. no. and date | DK/EP 3133396, 20180905 | | Publication date | 20170222 | | Priority no. and date | US 93234 P, 20080829 | | EP pub. no. and date |
EP 3133396 20170222 | | Effective date | | | Applicant/owner | Immedica Pharma AB, Norrtullsgatan 15
113 29 Stockholm, SE | | Applicant ref. no. | P66382DK01 | | Inventor | SCHARSCHMIDT, Bruce, Hyperion Therapeutics
601 Gateway Boulevard
Suite 200
South San Francisco, CA 94080, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | G01N 33/50 (2006.01) | | Title | FREMGANGSMÅDER TIL BEHANDLING UNDER ANVENDELSE AF AMMONIAKRENSENDE LÆGEMIDLER | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
